The 2023 Physician Fee Schedule conversion factor — which calculates how much a physician is reimbursed by Medicare for services — changed to $33.06, a $1.55 decrease from 2022 at $34.61. The American Medical Association strongly opposes the cuts.
Humana has been rolling out a model for primary care centers designed to accommodate the growing number of senior citizens in the U.S. Staffed by integrated care teams, the centers offer a holistic approach that addresses both the medical and social needs of patients.
By Stephanie Baum Thursday, November 3, 2022 7:30 AM
Executives from Huma, Abbott, Smith & Nephew and AliveCor share how they are using real world evidence collection to support remote patient monitoring, maximize patient engagement and navigate the regulatory landscape.
By Frank Vinluan Wednesday, November 2, 2022 7:17 PM
Rubius Therapeutics was unable to secure financing to carry out its pivot to a new manufacturing process for its red blood cell-based cell therapies. The once high-flying biotech is now exploring options that could include a sale of the business or a merger with another company.
By Katie Adams Wednesday, November 2, 2022 6:11 PM
Intus Care, a predictive analytics platform designed to improve care outcomes among geriatric patients, recently closed a $14.1 million Series A funding round. The startup's mission is to improve the way PACE programs use their data so they can maintain and enhance the quality of care they provide to vulnerable seniors.
By Katie Adams Wednesday, November 2, 2022 4:49 PM
Carta Healthcare recently closed a $20 million Series B financing round. , The company is a San Francisco-based provider of clinical data solutions, and its mission is to reduce the amount of time clinicians spend on mundane administrative tasks. Carta's technology is currently used at 245 hospitals across 18 health systems — the company will use its new funds to scale its customer base.
By Amanda James Wednesday, November 2, 2022 4:19 PM
The settlement terms are still being negotiated and the final settlement depends on the number of states, counties, and Native American tribes that agree to join
There needs to be a bigger emphasis and move towards connecting the life science companies who are doing the work of using biomarkers to develop therapies with the health systems where a majority of cancer care in the US actually occurs. Not enough patients are getting the benefit of precision medicine today. It starts with data sharing and real world evidence.
By Frank Vinluan Wednesday, November 2, 2022 1:25 PM
Alkermes says separating cancer from its portfolio and pipeline of neuroscience products could put the company on a path to profitability. Meanwhile, the new cancer company would be an independent and publicly traded entity with a lead immunotherapy in pivotal testing for two types of cancer.
By Dr. Jeffrey Williams Wednesday, November 2, 2022 9:00 AM
Voice-enabled technology powered by AI reduces documentation time by several hours per week, but physicians won't adopt a solution unless it's affordable and intuitive.
Today, the pharmaceutical industry is undergoing a rapid and dynamic transformation. Successful contract management plays an instrumental role in navigating this landscape.
No comments